ANI Pharmaceuticals
ANIP
#5000
Rank
ยฃ1.34 B
Marketcap
ยฃ59.22
Share price
1.18%
Change (1 day)
11.18%
Change (1 year)

EPS for ANI Pharmaceuticals (ANIP)

EPS in 2025 (TTM): ยฃ2.62

According to ANI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is ยฃ2.58. an increase over its 2024 EPS that were of -ยฃ0.83.

EPS history for ANI Pharmaceuticals from 2013 to 2025

Annual EPS

Year EPS Change
2025ยฃ2.48-400%
2024-ยฃ0.83
2022-ยฃ2.24-6.46%
2021-ยฃ2.3972.87%
2020-ยฃ1.38-476%
2019ยฃ0.37-62.12%
2018ยฃ0.97
2015ยฃ0.99-47.66%
2014ยฃ1.89-142.11%
2013-ยฃ4.48

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
ยฃ5.30 105.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
ยฃ1.00-61.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
ยฃ5.15 99.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
-ยฃ4.27-265.43%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Evoke Pharma
EVOK
-ยฃ1.86-172.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-ยฃ2.87-211.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ0.91-64.57%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Royalty Pharma
RPRX
ยฃ1.29-49.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lannett Company
LCI
-ยฃ18.62-822.29%๐Ÿ‡บ๐Ÿ‡ธ USA